Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar Disorder
Public ClinicalTrials.gov record NCT00107926. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Study identification
- NCT ID
- NCT00107926
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Novartis Pharmaceuticals
- Industry
- Enrollment
- 343 participants
Conditions and interventions
Conditions
Interventions
- Licarbazepine Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 30, 2004
- Primary completion
- Jul 31, 2007
- Completion
- Jul 31, 2007
- Last update posted
- Mar 21, 2017
2004 – 2007
United States locations
- U.S. sites
- 12
- U.S. states
- 10
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Investigational Site | La Palma | California | 90623 | — |
| Investigational Site | Kansas City | Kansas | 66160 | — |
| Investigational Site | Shreveport | Louisiana | 71101 | — |
| Investigational Site | Somerville | Massachusetts | 02143 | — |
| Investigational Site | Farmington Hills | Michigan | 48334 | — |
| Investigational Site | Staten Island | New York | 10305 | — |
| Investigational Site | Madison | Tennessee | 37115 | — |
| Investigational Site | Bellaire | Texas | 77401 | — |
| Investigational Site | Dallas | Texas | 75235 | — |
| Investigational Site | Bellevue | Washington | 98004 | — |
| Investigational Site | Kirkland | Washington | 98033 | — |
| Investigational Site | West Allis | Wisconsin | 53227 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 32 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00107926, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 21, 2017 · Synced May 14, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00107926 live on ClinicalTrials.gov.